Angiopep-2-cys is a conjugate of Angiopep-2 drochloride and cysteine. Angiopep-2 drochloride is a brain peptide vector. The conjugation of anticancer agents with the Angiopep-2 peptide vector could increase their efficacy in the treatment of brain cancer.
References:
[1]. Kafa H, et al. Translocation of LRP1 targeted carbon nanotubes of different diameters across the blood-brain barrier in vitro and in vivo. J Control Release. 2016 Mar 10;225:217-29.